Events

Presenter: Fusheng Wang, PhD
2020-11-20
Presenter: Xiaosong Wang, MD, PhD
2020-11-13
Presenter: Rebecca Hwa, PhD
2020-11-06
Presenter: Kim Unertl, PhD, MS
2020-10-30
Presenter: Allison McCoy, PhD, MS
2020-10-23
Presenter: Randi Foraker, PhD, MA, FAHA
2020-10-16
Presenter: Shandong Wu, PhD
2020-10-09
2020-10-02
Presenter: Lang Li, PhD

In this talk, translational pharmacoinformatics methods will be presented for the drug interaction research. They include literature based drug interaction discovery, drug interaction signal data mining from health record databases, translational drug interaction and pharmacogenetics studies, drug interaction knowledgebase for cancer phase I clinical trials, and target combination discovery for breast cancer chemo or PARP1 inhibitor resistance.

2020-09-25
Presenter: Daniel Normolle, PhD

The era of designs for clinical trials using Bayesian principles begins in 1990 with the publication of the Continual Reassessment Method, but until the mid 1990s, with the dissemination of flexible and powerful Markov Chain Monte Carlo software, only very simple models or models using conjugate priors were feasible.  Since then, the landscape has changed considerably and now it is possible to design clinical trials that adapt to accumulating data using mathematical mod

2020-09-18
^